Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial por Walter Suárez Carmona | Sep 21, 2025
Glucagon-like peptide-1 receptor agonists across the cardiovascular-kidney-metabolic spectrum: One size does not fit all por Walter Suárez Carmona | Sep 21, 2025
Clinical and Genetic Predictors of Non-Alcoholic Steatotic Liver Disease and Fibrosis in Lean Individuals por Walter Suárez Carmona | Sep 21, 2025
Classifying a distinct form of diabetes in lean individuals with a history of undernutrition: an international consensus statement por Walter Suárez Carmona | Sep 20, 2025
American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease — 2025 Update por Walter Suárez Carmona | Sep 20, 2025
